Basement membrane-related lncRNA signature for the prognosis of hepatocellular carcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers developed a new risk signature using basement membrane-related long non-coding RNAs (lncRNAs) to predict hepatocellular carcinoma (HCC) patient prognosis. This signature effectively identifies high-risk HCC patients with poorer outcomes, aiding clinical decisions.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Hepatocellular carcinoma (HCC) is a primary liver cancer with significant mortality.
- Prognostic biomarkers are crucial for managing HCC patients.
- Basement membrane (BM)-related long non-coding RNAs (lncRNAs) roles in HCC are underexplored.
Purpose Of The Study
- To develop a prognostic risk signature based on differentially expressed BM-related lncRNAs (DE-BMRlncRNAs) for HCC.
- To evaluate the signature's ability to predict overall survival in HCC patients.
- To establish a clinical decision-making tool for HCC prognosis.
Main Methods
- Screening of DE-BMRlncRNAs from HCC patient data.
- Development of a six-DE-BMRlncRNA prognostic signature (AC072054.1, NUP50-DT, AC026412.3, AC109322.2, POLH-AS1, LINC00595).
- Construction of a nomogram integrating risk score and clinicopathological features.
- Validation of lncRNA expression and functional analysis of POLH-AS1.
Main Results
- A six-DE-BMRlncRNA signature was identified and validated.
- Higher risk scores correlated with significantly worse HCC patient prognosis.
- The nomogram demonstrated utility in predicting clinical outcomes.
- POLH-AS1 knockdown suppressed HCC cell migration and invasion.
Conclusions
- A novel prognostic model based on DE-BMRlncRNAs can predict HCC patient outcomes.
- The identified lncRNAs, particularly POLH-AS1, may play roles in HCC progression.
- This study provides a foundation for developing BM-related biomarkers for HCC prognosis.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
